Veterinary composition and methods for production and use
Inventors
Eyal, Aharon M. • LIN-COHEN, Netta • LIN, Youval • Ariel, Meir
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-10675252-B2
Publication Date
2020-06-09
Expiration Date
Abstract
Veterinary compositions and methods for production and use. A method of treating bees at or near a bee hive with a first and/or second veterinary composition is described including administering to bees a veterinary composition comprising at least cannabinoid, and/or at least two non-cannabinoid cannabis compounds, with or without a carrier, thereby enhancing bees performance.
Core Innovation
The invention relates to treating bees at or near a bee hive by administering a therapeutically effective amount of a veterinary first composition. The veterinary first composition comprises at least one cannabinoid and/or at least two non-cannabinoid cannabis compounds, optionally together with a carrier. A second veterinary composition is also described as containing cannabinoids and/or non-cannabinoid cannabis compounds homogeneously dispersed in a carrier, optionally with water.
The disclosed approach addresses bee health in relation to virus, inflammation, stress, Colony Collapse Disorder (CCD), and Varroa, and includes enhancing reproduction, pollination activity, immune system function, and honey production. It also describes improvements in the number of bee hive brood cells, including sealed brood cells, and an increase in bee size, with bee hive trial outcomes that are reported as supporting these enhancements after administration at or near a hive.
The document further describes delivery and formulation variants for the compositions around the bee hive, including administering by vaporizing, spraying into the beehive atmosphere, spraying on honeycombs, and incorporating into beeswax used to form beehive frames. Additional refinements describe defined formulation and dispersion constraints, including carrier or water to cannabinoid weight-ratio constraints, and composition content that may include cannabis plant extract, terpenes, flavonoids, and other non-cannabinoid cannabis compounds, along with optional additives such as emulsifier and antioxidant.
Claims Coverage
The disclosed claim set contains one independent claim describing a bee-treatment method using a veterinary first composition with cannabinoids and/or non-cannabinoid cannabis compounds administered at or near a bee hive. The inventive features are refined by dependent claims that specify comparative outcomes, formulation weight-ratio constraints, and particular administration routes around the hive.
Treating bees at or near a bee hive with cannabinoid and non-cannabinoid cannabis compounds
A method of treating bees at or near a bee hive with a veterinary first composition by administering a therapeutically effective amount of the veterinary first composition comprising at least one cannabinoid and/or at least two non-cannabinoid cannabis compounds.
Reducing Varroa load by a comparative threshold
The method specifies that the average Varroa count in treated bees is at least 10% lower than in bees receiving no veterinary composition treatment.
Using a carrier or water to cannabinoid weight-ratio constraint
The method further comprises a carrier or water, where the ratio of the carrier or water to the cannabinoid by weight is greater than 5:1.
Administering by vaporizing, spraying, honeycomb application, or beeswax frame incorporation
The method includes administering the composition to a beehive by vaporizing it, spraying it into the beehive atmosphere, spraying it on honeycombs, or incorporating it into beeswax used to form beehive frames.
Including a cannabis plant material extract in the veterinary composition
The veterinary composition comprises an extract of cannabis plant material.
Enhancing outcomes including virus, inflammation, stress, CCD, Varroa, and brood/pollination/immune/honey production
The method defines enhancing to include treating bees for one or more of virus, inflammation, stress, Colony Collapse Disorder, and Varroa, and improving reproduction, pollination activity, immune system function, and honey production, including increasing bee hive brood cells and sealed brood cells.
Across the independent claim and its refinements, coverage centers on a bee-hive-adjacent treatment that administers a therapeutically effective amount of a veterinary first composition containing cannabinoids and/or at least two non-cannabinoid cannabis compounds. Dependent claim refinements specify hive delivery routes, formulation weight-ratio constraints, comparative reductions in Varroa load, inclusion of a cannabis plant material extract, and enhanced outcomes including virus, inflammation, stress, CCD, Varroa treatment alongside brood, pollination, immune, and honey production improvements.
Stated Advantages
Improved bee hive brood cells, including increased number of sealed brood cells.
Improved bee size.
Improved pollination activity and improved nectar and pollen collection.
Increased honey production.
Reduced Varroa load.
Treatment/enhancement directed to virus, inflammation, stress, and Colony Collapse Disorder (CCD).
Improved bees’ immune system.
Documented Applications
Veterinary treatment of bees at or near a bee hive using a cannabinoid and/or non-cannabinoid cannabis compound-containing veterinary first composition, administered by vaporizing, spraying into the beehive atmosphere, spraying onto honeycombs, or incorporating into beeswax used for frames.
Bee hive trial use cases reporting measured outcomes including brood and sealed brood cell counts, bee size, pollination activity, nectar and pollen collection, honey yield, and Varroa counts, with enhancements framed around virus, inflammation, stress, CCD, and related bee health effects.
Interested in licensing this patent?